At a glance
- Originator sanofi-aventis
- Developer Sanofi
- Class Imidazoles
- Mechanism of Action Angiotensin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cardiovascular disorders
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cardiovascular-disorders in Germany (PO)
- 19 Jun 2008 AVE-0991 is still in preclinical trials for Cardiovascular disorders in Germany